Johns Hopkins University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count).
Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.
Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.
Top-decile sponsor footprint
Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
943 of 1,108 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,448 total, page 9 of 29
Everolimus Trial in Laryngotracheal Stenosis
NCT05153668
Ablation at Virtual-hEart pRedicted Targets for VT
NCT03536052
Breast and Cervical Cancer Education Program
NCT06365450
ARMS: The Arm Rest and Support Study
NCT05372328
Determining Change In Blood Pressure Due to Environment and Loudness
NCT05394376
Thriving Together: Supporting Resilience in the Healthcare Workforce
NCT05321381
Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension
NCT04039464
Acute Pharmacokinetic and Pharmacodynamic Effects of "Tobacco-Free" Oral Nicotine Pouches in Smokers
NCT05335915
Self-Management of Chronic Low Back Pain: Targeting Patient Activation
NCT06236529
Family Diabetes Prevention Program Pilot Study
NCT05358444
Effects of Psilocybin in Post-Treatment Lyme Disease
NCT05305105
Virtual Group Psychoeducational Discussions With Spanish-Speaking Mothers of Infants in Pediatric Primary Care
NCT05423093
Investigating Distress Tolerance in Adults With Tourette Syndrome
NCT05047705
Implementation and Evaluation of a Diabetes Prevention Clinical Pathway in Primary Care
NCT05265312
Comparative Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC
NCT05287256
Bimanual Arm Training in Acute Stroke
NCT05106595
Development of Discharge Education Video for Solid Organ Transplant Recipients
NCT05189340
Making Health Care Safer for Older Adults Receiving Skilled Home Health Care Services After Hospital Discharge
NCT05182060
Heart Failure Resilience Intervention for Caregivers
NCT03963583
Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of Care
NCT05366842
Virtual Reality as a Substitute for Procedural Sedation During Epidural Steroid Injections
NCT04887285
Sodium Citrate 4% Locking Solution for Children Requiring Home Parenteral Nutrition
NCT04756427
Pilot Study of reSET-O to Treatment-as-usual in Acute Care Settings
NCT04817267
CAPABLE Family Pilot - Adapting CAPABLE for Older Adults With Mild Cognitive Impairment (MCI)/Early Stage Dementia and Their Care Partners
NCT05187117
Glycemic Effects of the COVID-19 Booster Vaccine in Type 1 Diabetes
NCT05233592
The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A
NCT05049733
MEMORI Corps: Activity-based Companion Care for Dementia
NCT03896711
Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection
NCT05236387
Reduced Nicotine Cigarette Purchasing Decisions
NCT04999644
The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment
NCT04931095
Patient Engagement in Perioperative Pain Management Project
NCT05252767
Sound and Music for Mild Cognitive Impairment
NCT05064007
Neodymium-doped Yttrium Aluminum Garnet (Nd:YAG) Laser Treatment for Granular Corneal Dystrophy
NCT06202651
User-Led Meaningful Activity and Early-Stage Dementia
NCT05159869
Preventing Recurrent UTI With Vaginal Estrogen
NCT05551949
Pilot Testing a Computer Delivered Tobacco Cessation Intervention in Outpatient Clinical Settings: A Feasibility Study
NCT05145738
Radiofrequency Ablation of Papillary Thyroid Microcarcinoma
NCT05132205
Preventing Anaphylaxis With Acalabrutinib
NCT05038904
Assessing Brain Injury Using Portable Magnetic Resonance Imaging (MRI)
NCT05469139
ACCESS: AI for pediatriC diabetiC Eye examS Study
NCT05131451
A Virtual Cardiometabolic Health Program for African Immigrants: The Afro-DPP Program
NCT05144737
Leveraging Technological Advancements to Improve the Treatment of Trichotillomania
NCT05003401
ACHIEVE Hearing Intervention Follow-Up Study
NCT05070429
Anesthesia Counseling, Consent, & Professionalism
NCT06010836
Comparing AlloDerm and DermACELL in Breast Reconstruction
NCT04710537
Evaluation of a Tai Chi Resilience Training Program on Objective and Subjective Measures of Post Traumatic Stress Disorder Severity
NCT04288830
Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation
NCT03846830
Effectiveness and Cost-Effectiveness of Fully-Automated Digital vs. Human Coach-Based Diabetes Prevention Programs
NCT05056376
Opioid Reduction Initiative During Outpatient Pediatric Urologic Procedures Using Exparel
NCT04826484
Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis
NCT04767698
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 201 |
| Phase 2 | 198 |
| Phase 3 | 44 |
| Phase 4 | 81 |
Therapeutic Areas
What is open in the Johns Hopkins University pipeline
250 recruiting of 1,448 indexed (17% open); 943 completed (65%).
Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).
Top condition: Hypertension (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Johns Hopkins University: open-pipeline peers nationwide
Peers matched on 1,448 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Johns Hopkins University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,448 trials (± recruiting share)
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Yale University · 1,492 trials · 17% recruiting
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Seattle Children's Hospital · 17% recruiting · 168 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
- Virginia Polytechnic Institute and State University · 17% recruiting · 104 trials
Related
What to do with this Johns Hopkins University page
1,448 registered trials is a research-attention snapshot, not an endorsement of Johns Hopkins University or any single study.
- 250 of Johns Hopkins University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Johns Hopkins University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Johns Hopkins University pipeline card: 1,448 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.